These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17258675

  • 1. [Drug treatment of type 2 diabetes].
    Tielmans A, Laloi-Michelin M, Coupaye M, Virally M, Meas T, Guillausseau PJ.
    Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus].
    Valerón PF, de Pablos-Velasco PL.
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():20-5. PubMed ID: 24444520
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New therapeutic approaches in type 2 diabetes.
    Scheen AJ.
    Acta Clin Belg; 2008 Sep; 63(6):402-7. PubMed ID: 19170358
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.
    McIntosh B, Cameron C, Singh SR, Yu C, Ahuja T, Welton NJ, Dahl M.
    Open Med; 2011 Sep; 5(1):e35-48. PubMed ID: 22046219
    [Abstract] [Full Text] [Related]

  • 19. New avenues for the pharmacological management of type 2 diabetes: an update.
    Cuny T, Guerci B, Cariou B.
    Ann Endocrinol (Paris); 2012 Nov; 73(5):459-68. PubMed ID: 23078974
    [Abstract] [Full Text] [Related]

  • 20. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    Duffy NA, Green BD, Irwin N, Gault VA, McKillop AM, O'Harte FP, Flatt PR.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):278-86. PubMed ID: 17573070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.